Your shopping cart is empty!
Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
Catalog: | HY-B1367 |
Brand: | MCE |
CAS: | 7421-40-1 |
MDL | - |
---|---|
Molecular Weight | 614.72 |
Molecular Formula | C34H48Na2O7 |
SMILES | CC(C)([C@]1([H])CC[C@@]([C@@]2(CC[C@]3(CC[C@](C[C@@]3([H])C2=C4)(C)C(O[Na])=O)C)C)5C)[C@@H](OC(CCC(O[Na])=O)=O)CC[C@]1(C)[C@@]5([H])C4=O |
Carbenoxolone disodium is the active metabolite of Glycyrrhizic acid (HY-N0184) and the inhibitor of human 11β-HSD and bacterial 3α, 20β-HSD [1] . Carbenoxolone disodium is an uncoupling agent for gap junctions and a potent inhibitor of Vaccinia virus replication [2] . Carbenoxolone disodium is used for the study of peptic, esophageal and oral ulceration and inflammation. Carbenoxolone disodium inhibits Vaccinia virus replication.
Carbenoxolone disodium (6-150 μM; pre-treatment 1 hour) inhibits
Vaccinia
virus (VACV) replication in a gap junction-independent in HaCaT cells, and it has toxicity effects on VACV-A5L-EGFP infected cells at 48 h
[2]
.
Carbenoxolone (30 μM; pre-treatment 1 hour) does not upregulate PP2A expression, but induces the late protein A27 expression in hacat cells
[2]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Viability Assay [2]
Cell Line: | HaCaT cells |
Concentration: | 6 μM, 12 μM, 30 μM, 60 μM, 150 μM |
Incubation Time: | Pre-treatment 1 hour |
Result: | Had no toxicity until 48 hours at high dose in virus-infected cells. |
Western Blot Analysis [2]
Cell Line: | HaCaT cells |
Concentration: | 30 μM |
Incubation Time: | Pre-treatment 1 hour |
Result: | Presented an obvious upregulation of A27. |
Carbenoxolone (intraperitoneal injection; 100, 200 and 300 mg/kg; 30, 60 and 60 min before Diazepam) does not induce a muscle relaxant activity and shows muscle relaxant activity compared to normal saline, and this effect was more than diazepam in the traction test
[3]
.
Carbenoxolone (intraperitoneal injection; 100, 200 and 300 mg/kg; 30, 60 and 60 min before Pentylenetetrazole) significantly increases sleeping time and decreases latency in mice as a dose-dependent manner in Pentylenetetrazole (PTZ) Seizure model. The ED
50
value is 83.3 mg/kg (%95 CL:556.29)
[3]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: | Male BALB/c mice [3] |
Dosage: | 100, 200 and 300 mg/kg |
Administration: | Intraperitoneal injection; 30, 60 and 60 min before Pentylenetetrazole |
Result: | Significantly increased the sleeping time in mice. |
Solid
Room temperature in continental US; may vary elsewhere.
-20°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
H 2 O : 50 mg/mL ( 81.34 mM ; Need ultrasonic)
DMSO : 16.67 mg/mL ( 27.12 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 1.6268 mL | 8.1338 mL | 16.2676 mL |
5 mM | 0.3254 mL | 1.6268 mL | 3.2535 mL |
10 mM | 0.1627 mL | 0.8134 mL | 1.6268 mL |
Add each solvent one by one: PBS
Solubility: 6.25 mg/mL (10.17 mM); Clear solution; Need ultrasonic and warming and heat to 60°C
Add each solvent one by one: 10% DMSO >> 90% corn oil
Solubility: ≥ 1.67 mg/mL (2.72 mM); Clear solution
Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)
Solubility: ≥ 0.93 mg/mL (1.51 mM); Clear solution
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.